<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03039478</url>
  </required_header>
  <id_info>
    <org_study_id>PolyDose</org_study_id>
    <nct_id>NCT03039478</nct_id>
  </id_info>
  <brief_title>Effect of Different Concentrations of Xylitol and Erythritol on Gut Peptide Release and Gastric Emptying in Humans</brief_title>
  <official_title>Effect of Different Concentrations of Xylitol and Erythritol on the Release of Gastrointestinal Peptides and on Gastric Emptying Rates in Healthy Normal Weight Humans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Xylitol and erythritol have become increasingly popular as sugar substitutes in the food
      industry. Both substances are freely available. While glucose ingestion stimulates satiation
      hormone secretion in the gut and slows down gastric emptying, artificial sweeteners such as
      aspartame, sucralose and acesulfame-K have no such effect. However, acute intake of 50g
      xylitol or 75g erythritol in 300mL tap water leads to a marked increase in the satiation
      hormones and induces a significant retardation in gastric emptying. The concentrations used
      to Show this effect were rather high (50g xylitol and 75g erythritol) and led to bloating and
      diarrhea in 60-70% of all subjects two hours after administration. The aim of the present
      study is to find an effective concentration of xylitol and erythritol still stimulating
      satiation hormone release without any gastrointestinal adverse events.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 24, 2017</start_date>
  <completion_date type="Anticipated">July 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">July 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Parallel assignment</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Acute effect on cholecystokinin ( CCK) release</measure>
    <time_frame>changes from baseline to three hours after treatment</time_frame>
    <description>effect on CCK release measured by a commercially available ELISA kit (enzyme-linked immunosorbent assay)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Acute effects on gastric emptying</measure>
    <time_frame>changes from baseline to three hours after treatment</time_frame>
    <description>Acute effects on gastric emptying measured by 13C-sodium-acetate breath test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute effects on subjective feelings of hunger and satiety</measure>
    <time_frame>changes from baseline to three hours after treatment</time_frame>
    <description>Acute effects on subjective feelings of hunger and satiety measured by visual analogue scales</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Physiological Satiation Mechanisms</condition>
  <arm_group>
    <arm_group_label>Xylitol 7g in 300mL tap water</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>12 volunteers receive 7g xylitol in 300mL tap water via a nasogastric tube</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Xylitol 17g in 300mL tap water</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>12 volunteers receive 17g xylitol in 300mL tap water via a nasogastric tube</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Xylitol 35g in 300mL tap water</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>12 volunteers receive 35g xylitol in 300mL tap water via a nasogastric tube</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Erythritol 10g in 300mL tap water</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>12 volunteers receive 10g erythritol in 300mL tap water via a nasogastric tube</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Erythritol 25g in 300mL tap water</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>12 volunteers receive 25g erythritol in 300mL tap water via a nasogastric tube</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Erythritol 50g in 300mL tap water</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>12 volunteers receive 50g erythritol in 300mL tap water via a nasogastric tube</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Xylitol 7g</intervention_name>
    <description>Xylitol 7g in 300mL tap water</description>
    <arm_group_label>Xylitol 7g in 300mL tap water</arm_group_label>
    <other_name>E967-Xylitol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Erythritol 10g</intervention_name>
    <description>Erythritol 10g in 300mL tap water</description>
    <arm_group_label>Erythritol 10g in 300mL tap water</arm_group_label>
    <other_name>E968-Erythritol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Xylitol 17g</intervention_name>
    <description>Xylitol 17g in 300mL tap water</description>
    <arm_group_label>Xylitol 17g in 300mL tap water</arm_group_label>
    <other_name>E967-Xylitol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Xylitol 35g</intervention_name>
    <description>Xylitol 35g in 300mL tap water</description>
    <arm_group_label>Xylitol 35g in 300mL tap water</arm_group_label>
    <other_name>E967-Xylitol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Erythritol 25g</intervention_name>
    <description>Erythritol 25g in 300mL tap water</description>
    <arm_group_label>Erythritol 25g in 300mL tap water</arm_group_label>
    <other_name>E968-Erythritol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Erythritol 50g</intervention_name>
    <description>Erythritol 50g in 300mL tap water</description>
    <arm_group_label>Erythritol 50g in 300mL tap water</arm_group_label>
    <other_name>E968-Erythritol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy normal weight subjects with a body-mass index of 19.0-24.9

          -  Normal eating habits (no diets; no dietary changes; no special dietary habits, such as
             vegetarian/vegan)

          -  Age 18-40 years

          -  Stable body weight for at least three months

          -  Informed Consent as documented by signature

        Exclusion Criteria:

          -  Pre-existing consumption of xylitol or erythritol on a regular basis (usage of xylitol
             or erythritol as sugar replacement; xylitol or erythritol containing toothpaste is
             allowed)

          -  Regular intake of medications (except for oral contraceptives)

          -  Evidence of relevant cardiovascular, pulmonary, renal, hepatic, pancreatic,
             gastrointestinal, metabolic, endocrinological, neurological, psychiatric or other
             diseases at screening

          -  Clinically relevant abnormalities in haematological laboratory parameters

          -  Food allergies, food intolerance

          -  Pregnancy

          -  Participation in another study with investigational drug within the 30 days preceding
             and during the present study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christoph Beglinger, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Basel, Switzerland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bettina K WÃ¶lnerhanssen, MD</last_name>
    <phone>+ 41 61 685 85 85 Zentrale</phone>
    <email>bettina.woelnerhanssen@usb.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christoph Beglinger, Prof</last_name>
    <phone>+ 41 61 685 85 85 Zentrale</phone>
    <email>christoph.beglinger@unibas.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Basel</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bettina K Woelnerhanssen, MD</last_name>
      <email>bettina.woelnerhanssen@usb.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 31, 2017</study_first_submitted>
  <study_first_submitted_qc>January 31, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2017</study_first_posted>
  <last_update_submitted>August 30, 2017</last_update_submitted>
  <last_update_submitted_qc>August 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Erythritol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

